Carlos Doti: I’m Reminded Why ASH is Such a Powerful Close to The Year
Carlos Doti, VP US Medical Affairs Oncology at AstraZeneca, shared on LinkedIn:
”As I reflect on another ASH, I’m reminded why this meeting is such a powerful close to the year – where science, collaboration and patient experiences come together to shape the future of hematology.
This year, I participated in two meaningful AstraZeneca events:
Moderating our annual Patient Advocacy Exchange panel with advocacy leaders focused on shared decision-making and patient navigation, discussing how to break down barriers and promote equitable access to care.
Hosting our first-ever AZHemeTalks – a live, pop-up series – at our booth, where I spoke with a clinical trial patient and her doctor about how treatment choices impact daily life.
The video here shows how we brought this activation to life through 4 expert panels focused on the treatment landscape in leukemia, lymphomas and multiple myeloma.”
Stay updated with Hemostasis Today.
-
Jul 6, 2026, 14:48Muhammad Salman Babar: Why Vitamin B12 Treatment Can Lower Potassium
-
Jul 6, 2026, 14:30Abhijit Majumder: Deep Vein Thrombosis – A Silent but Preventable Medical Emergency
-
Jul 6, 2026, 14:26Why Factor XI Deficiency Deserves Greater Awareness – Haemophilia Foundation Australia
-
Jul 6, 2026, 14:17Yoon-Sik Kang: Low-Blood-Loss Hernia Repair Aims to Reduce Perioperative Risk
-
Jul 6, 2026, 14:14Soledad Molnar: Global Practice Patterns in Pregnancy-Associated Thromboprophylaxis
-
Jul 6, 2026, 13:53Ney Carter Borges: Bempedoic Acid Shows a Promising VTE Signal in CLEAR Outcomes Analysis
-
Jul 6, 2026, 13:37Rachad Zayat: Acute PE Study Finds USAT Associated With Better In-Hospital Outcomes
-
Jul 6, 2026, 13:28Inna Vilshanivska: Sharing Ukraine’s Experience in Blood Donor Retention at the ISBT 2026
-
Jul 6, 2026, 13:10Arun V. J.: Did You Know A Glass Of Water is The Best Way To Retain A Blood Donor?